Bell Biosystems
VerifiedBell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$15—23m (Dealroom.co estimates Apr 2015.)
San Francisco California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | $0.0 | round |
| investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
$3.8m | Series A | ||
| Total Funding | 000k | ||
Related Content
Recent News about Bell Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.